Are we treating long COVID wrong? Immune-boosting treatment takes new approach
Medical News Today: Rajeev Mehlotra, research associate at the School of Medicine, discussed treatment of long COVID. “As the studies targeting CCR5 for COVID-19 treatment are performed, and such treatments start becoming increasingly available, this study adds another view to the mechanism associated with leronlimab treatment,” said Mehlotra.
